Quinisocaine
From Wikipedia, the free encyclopedia
 |
|
|
Quinisocaine
|
|
| Systematic (IUPAC) name | |
| 2-(3-butylisoquinolin-1-yl)oxy-N,N-dimethyl-ethanamine | |
| Identifiers | |
| CAS number | |
| ATC code | D04 |
| PubChem | |
| Chemical data | |
| Formula | C17H24N2O |
| Mol. mass | 272.385 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Quinisocaine (INN) or dimethisoquin (BAN and USAN) is a topical anesthetic used as an antipruritic.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||
